Researchers at King’s College London have mapped how the immune response in people with sepsis changes over time, in findings published in Immunity on 28 August 2026. The study offers a more detailed view of a condition that remains life-threatening even when treated quickly, and could help explain why current approaches have struggled to improve outcomes.
A closer look at a fast-moving medical emergency
Sepsis occurs when the immune response to infection misfires, leading to organ failure and, in severe cases, death. The researchers said the new work was designed to better understand the immune mechanisms that evolve during the illness, rather than looking at the condition as a single static event.
The study used machine learning to track changes in immune response over time, building on the recognition that sepsis is not caused by a single biological pathway. Current treatment focuses on antimicrobial therapy and supportive care for failing organs, but efforts to directly correct the immune dysfunction have so far not delivered improved outcomes for patients.
Why the timing of the immune response matters
According to the report, sepsis remains difficult to treat because the body’s response to infection can shift rapidly, making it hard for clinicians and researchers to identify which immune signals are harmful, which are protective, and when those changes occur. By mapping these changes over time, the study aims to provide a more precise framework for future research.
The findings add to earlier recent work on sepsis from other groups, including research suggesting that the NEWS2 score may help clinicians decide which patients are most likely to benefit from immediate antibiotics. Together, these studies reflect a broader effort to improve early decision-making in suspected sepsis and to better match treatment intensity to patient risk.
What the study could mean for future care
The researchers said the new analysis was intended to improve understanding of the mechanisms that change during sepsis, which may eventually support more targeted therapies. For now, the work is primarily a research advance, but it could help point future studies toward the most relevant immune targets.
Sepsis is estimated to affect more than 160 million people globally each year and causes about 21 million deaths worldwide, underscoring the scale of the problem researchers are trying to solve. The latest findings do not change treatment today, but they add important detail to one of medicine’s most urgent unanswered questions: how to stop the immune system from turning a treatable infection into a fatal emergency.
For more on the study context, see the original report and recent medical coverage.
Photo source: AI-generated or edited image
